Robert Grieve

Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial

David Sebag‐Montefiore, Richard Stephens, R. Steele et al. · The Lancet · 2009 · 1.5K citations · Full text

Surgical Oncology, Health Sciences, Radiation Therapy +9

Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial

Philip Quirke, R. Steele, John R.T. Monson et al. · The Lancet · 2009 · 1K citations · Full text

Surgical Oncology, Gastrointestinal Oncology, Colorectal Surgery +10

aTTom: Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years in 6,953 women with early breast cancer.

Richard Gray, Daniel Rea, Kelly Handley et al. · Journal of Clinical Oncology · 2013 · 446 citations

Breast Oncology, Cancer Management, Epidemiology Of Cancer +17

Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial

Robert E. Coleman, David Cameron, David Dodwell et al. · The Lancet Oncology · 2014 · 290 citations

Breast Oncology, Early Breast Cancer, Medicine +9

6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial

Helena Earl, Louise Hiller, Anne-Laure Vallier et al. · The Lancet · 2019 · 277 citations · Full text